Recombinant VEGFR2/CD309 anticorps

N° du produit ABIN1589715

Cet anticorps anti-VEGFR2/CD309 est un anticorps Souris Monoclonal détectant VEGFR2/CD309 dans ELISA et FACS. Adapté pour Humain.

Aperçu rapide pour Recombinant VEGFR2/CD309 anticorps (ABIN1589715)

Antigène: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Type d'anticorp: Recombinant Antibody

Fragment: scFv fragment

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp VEGFR2/CD309 est non-conjugé

Application: ELISA, Flow Cytometry (FACS)

Détail du produit anti-VEGFR2/CD309 anticorps

Expression System: Escherichia coli (E. coli)

Fonction: VEGFR-2/sc-Fv (single chain) antibody

Attributs du produit: Anti-human VEGFR-2 single chain (VEGFR-2 sc-Fv) antibody was constructed from cDNA of mice immunized with highly purified soluble VEGFR-2 protein expressed in insect cells. Anti-human VEGFR-2 sc-Fv was produced in E. coli and affinity purified.

Information d'application

Indications d'application: FACS: Use at 0.5-5 μg/mL, ELISA

Restrictions: For Research Use only

Stockage

Format: Frozen

Reconstitution: Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

Buffer: 150 mM NaCl, 150 mM NaP, pH 7.2

Stock: -20 °C,-80 °C

Stockage commentaire: The single chain antibody is supplied as frozen liquid (concentration please see vial label). For long time storage we recommend storage at -20°C to -70°C.

Date de péremption: 24 months

Détails sur VEGFR2/CD309

Antigène: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Autre désignation: VEGFR-2

Sujet: Vascular endothelial growth factor receptor-2 , KDR, FLK1, CD309, VEGF receptor 2, kinase insert domain protein receptor,Anti-human VEGFR-2 single chain (VEGFR-2 sc-Fv) antibody was constructed from cDNA of mice immunized with highly purified soluble VEGFR-2 protein expressed in insect cells. Anti-human VEGFR-2 sc-Fv was produced in E. coli and affinity purified.

ID gène: 3791

NCBI Accession: NM_002253, NP_002244

UniProt: P35968

Pathways: Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling